GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » AroCell AB (OSTO:AROC) » Definitions » Other Net Income (Loss)

AroCell AB (OSTO:AROC) Other Net Income (Loss) : kr0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is AroCell AB Other Net Income (Loss)?

AroCell AB's Other Net Income (Loss) for the three months ended in Mar. 2024 was kr0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.00 Mil.


AroCell AB Other Net Income (Loss) Historical Data

The historical data trend for AroCell AB's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AroCell AB Other Net Income (Loss) Chart

AroCell AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Net Income (Loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

AroCell AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

AroCell AB Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AroCell AB Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of AroCell AB's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


AroCell AB (OSTO:AROC) Business Description

Traded in Other Exchanges
N/A
Address
Uppsala Business Park, Virdings allé 32 B, Uppsala, SWE, 754 50
AroCell AB is working in the area of cancer diagnostics. The company develops and commercializes markers for the determination of cell growth and apoptosis, clinically useful for prognosis, monitoring, and follow-up of cancer patients in Sweden.

AroCell AB (OSTO:AROC) Headlines

From GuruFocus

Archrock Announces Quarterly Cash Dividend

By GlobeNewswire GlobeNewswire 10-27-2022

Archrock Announces Quarterly Cash Dividend

By GlobeNewswire GlobeNewswire 07-28-2022

Archrock Announces Timing for First Quarter 2023 Results

By sperokesalga sperokesalga 04-25-2023

Archrock Announces Quarterly Cash Dividend

By Value_Insider Value_Insider 10-27-2022

Archrock Announces Timing for Fourth Quarter 2021 Results

By GuruFocusNews GuruFocusNews 02-10-2022

Archrock Announces Quarterly Cash Dividend

By Marketwired Marketwired 10-28-2021

Archrock Announces Quarterly Cash Dividend

By GlobeNewswire 10-26-2023

Archrock Announces Timing for Fourth Quarter 2022 Results

By sperokesalga sperokesalga 02-13-2023